4,166,667 SHARES OF COMMON STOCK AYTU BIOSCIENCE, INC. AMENDED AND RESTATED UNDERWRITING AGREEMENTUnderwriting Agreement • December 14th, 2020 • Aytu Bioscience, Inc • Pharmaceutical preparations • New York
Contract Type FiledDecember 14th, 2020 Company Industry JurisdictionAytu BioScience, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule V hereto (the “Underwriters”), for whom H.C. Wainwright & Co., LLC is acting as representative (the “Representative”), an aggregate of 4,166,667 authorized but unissued shares (the “Firm Shares”) of the Company’s common stock, $0.0001 par value per share (the “Common Stock”) and, at the election of the Underwriters, upon the terms and conditions stated herein, up to 625,000 additional shares (the “Additional Shares” and, together with the Firm Shares, the “Shares”) of Common Stock solely to cover over-allotments, if any (the Shares, the Underwriter Warrants (as defined below) and the Underwriter Warrant Shares (as defined below) being collectively referred to herein as the “Securities”). This Amended and Restated Underwriting Agreement amends, restates and supersedes in its entirety the underwriting agreement
5,250,000 SHARES ORAMED PHARMACEUTICALS INC. COMMON STOCK UNDERWRITING AGREEMENTUnderwriting Agreement • February 28th, 2020 • Oramed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 28th, 2020 Company Industry JurisdictionOramed Pharmaceuticals Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule V hereto (the “Underwriters”), for whom National Securities Corporation is acting as representative (the “Representative”), an aggregate of 5,250,000 authorized but unissued shares (the “Firm Shares”) of the Company’s common stock, $0.012 par value per share (the “Common Stock”), and, at the election of the Underwriters, upon the terms and conditions stated herein, up to 787,500 additional shares (the “Additional Shares”) of Common Stock solely to cover over-allotments, if any (the Firm Shares and the Additional Shares that the Underwriters elect to purchase pursuant to Section 3 hereof being collectively called the “Securities”).
Shares of Common Stock and ______ Warrants to Purchase Shares of Common Stock MYND ANALYTICS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • June 2nd, 2017 • MYnd Analytics, Inc. • Services-misc health & allied services, nec • New York
Contract Type FiledJune 2nd, 2017 Company Industry Jurisdiction
GOOD TIMES RESTAURANTS INC. UNDERWRITING AGREEMENTUnderwriting Agreement • June 27th, 2013 • Good Times Restaurants Inc • Retail-eating places • New York
Contract Type FiledJune 27th, 2013 Company Industry JurisdictionGood Times Restaurants Inc., a Nevada corporation (the “Company”), confirms its agreement, subject to the terms and conditions set forth herein, with each of the underwriters listed on Exhibit A hereto (collectively, the “Underwriters”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), to sell and issue to the Underwriters an aggregate of ________ shares (the “Shares”) of common stock, par value $0.001 per share, of the Company (“Common Stock”) and warrants (each, a “Warrant” and collectively, the “Warrants”) to purchase an aggregate of _____ shares of Common Stock at an exercise price equal to $____. Each Share shall be accompanied by a Warrant to purchase an additional one-half share of Common Stock (collectively, a “Unit”).